Latest Pandemics Stories
Powerful Personal Videos Reveal the Impact of HIV And Urge Others to #SpeakOutHIV MENLO PARK, Calif., Sept.
BEIJING, Sept. 5, 2014 /PRNewswire/ -- Sinovac Biotech Ltd.
BEIJING, Sept. 2, 2014 /PRNewswire/ -- Sinovac Biotech Ltd.
BEIJING, Aug. 27, 2014 /PRNewswire/ -- Sinovac Biotech Ltd.
New Analysis Provides Basis for a Synthetic Influenza H1N1 Blocker-Vaccine Candidate, Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ -- An analysis by Replikins, Ltd.
MarketReportsOnline.com adds "Global Influenza (Flu) Vaccine Market: Trends & Opportunities (2014-19)" report to its research store. Dallas, Texas
High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications.
The North American Swine Feed & Feed Additives Market report defines and segments the swine feed & feed additives market in North America with analysis and forecast of revenue.
GIA announces the release of a comprehensive global report on Hand Sanitizers markets.
LONDON, July 30, 2014 /PRNewswire/ -- Replikins Ltd. today released new data on changes in the gene structure of the Ebola virus.
Vibrio cholerae is a gram negative comma-shaped bacterium with a polar flagellum that causes cholera in humans. V. cholerae belongs to the gamma subdivision of the Proteobacteria. Classical and El Tor are the two types of V. Cholerae identified by hemaggluttination testing. El Tor is found throughout the world, while the classical biotype is found only in Bangladesh. It was first isolated as the cause of cholera by Italian anatomist Filippo Pacini in 1854; however, this discovery was not...
- The parings of haberdine; also, any kind of fragments.
More Images (5 images) »